Viral specific T cell therapy in kidney transplant recipients - A single-center experience.

Manish Anand,Jake Nysather,Gregory McGraw,Senu Apewokin,Ruby Khoury,Michael S Grimley,Shalini Bumb,Amit Govil

Transplant infectious disease : an official journal of the Transplantation Society（2023）

引用 0|浏览5

暂无评分

摘要

Patients that are resistant to antivirals or who have worsening viremia despite conventional management may benefit from VSTs therapy to treat underlying viral infection. Additional studies are needed to ascertain efficacy and short- and long-term risks secondary to VSTs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要